OPKO Health will participate in the J.P. Morgan Healthcare Conference, hosting meetings and a live webcast on January 14.
Quiver AI Summary
OPKO Health, Inc. announced its participation in the 44th Annual J.P. Morgan Healthcare Conference, taking place from January 12-15, 2026, in San Francisco. The company's management will engage in one-on-one meetings with investors and participate in a fireside chat scheduled for January 14 at 1:30 p.m. Pacific time, which will be webcast live and available for replay on OPKO's website. OPKO Health is a biopharmaceutical and diagnostics firm focused on leveraging its innovative technologies to lead in rapidly growing markets. For more details, visit their website.
Potential Positives
- OPKO Health, Inc. will showcase its commitment to investor relations by participating in the prestigious 44th Annual J.P. Morgan Healthcare Conference.
- The company will host one-on-one meetings with investors, indicating a proactive approach to building relationships and attracting investment interest.
- The opportunity for a live webcast of the fireside chat expands reach and accessibility for investors and stakeholders.
Potential Negatives
- Management's participation in the conference may highlight a lack of significant new developments or announcements, potentially indicating stagnation in the company’s progress or innovation.
- The need for one-on-one investor meetings could suggest that the company is struggling to generate broader interest or confidence in its current strategy and performance.
- Hosting a fireside chat indicates an attempt to engage with investors, which could reflect ongoing concerns about market perception and company transparency.
FAQ
When will OPKO Health participate in the J.P. Morgan Healthcare Conference?
OPKO Health will participate in the conference from January 12-15, 2026.
What is the date and time of OPKO Health's fireside chat?
The fireside chat is scheduled for January 14th at 1:30 p.m. Pacific time.
How can I watch the OPKO Health fireside chat?
The fireside chat will be webcast live and available for replay on OPKO Health’s website.
Where is the J.P. Morgan Healthcare Conference being held?
The conference will take place at the Westin St. Francis Hotel in San Francisco.
What does OPKO Health specialize in?
OPKO Health specializes in biopharmaceuticals and diagnostics, focusing on large, rapidly growing markets.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$OPK Insider Trading Activity
$OPK insiders have traded $OPK stock on the open market 34 times in the past 6 months. Of those trades, 34 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OPK stock by insiders over the last 6 months:
- PHILLIP MD ET AL FROST (CEO & Chairman) has made 34 purchases buying 3,098,300 shares for an estimated $4,082,591 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OPK Hedge Fund Activity
We have seen 105 institutional investors add shares of $OPK stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WEISS ASSET MANAGEMENT LP removed 3,626,221 shares (-76.2%) from their portfolio in Q3 2025, for an estimated $5,620,642
- MARSHALL WACE, LLP removed 3,348,166 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,189,657
- WHITEFORT CAPITAL MANAGEMENT, LP added 3,125,800 shares (+176.2%) to their portfolio in Q3 2025, for an estimated $4,844,990
- AQR CAPITAL MANAGEMENT LLC added 1,937,516 shares (+207.0%) to their portfolio in Q3 2025, for an estimated $3,003,149
- GRAHAM CAPITAL MANAGEMENT, L.P. removed 1,812,763 shares (-94.9%) from their portfolio in Q3 2025, for an estimated $2,809,782
- BLACKROCK, INC. added 1,722,902 shares (+5.5%) to their portfolio in Q3 2025, for an estimated $2,670,498
- MORGAN STANLEY removed 1,221,453 shares (-59.3%) from their portfolio in Q3 2025, for an estimated $1,893,252
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OPK Price Targets
Multiple analysts have issued price targets for $OPK recently. We have seen 2 analysts offer price targets for $OPK in the last 6 months, with a median target of $1.925.
Here are some recent targets:
- Maury Raycroft from Jefferies set a target price of $1.6 on 10/31/2025
- Michael Petusky from Barrington Research set a target price of $2.25 on 10/30/2025
Full Release
MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK ) announced today that management will be participating in the 44 th Annual J.P. Morgan Healthcare Conference, being held January 12-15, 2026, at the Westin St. Francis Hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, January 14 th at 1:30 p.m. Pacific time.
The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website here .
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com .
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
[email protected]
or
Bruce Voss, 310-691-7100
[email protected]
